UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017182 |
|---|---|
| Receipt number | R000019936 |
| Scientific Title | Phase II clinical trial of S-1/L-OHP+Trastuzumab for HER2 positive gastric cancer |
| Date of disclosure of the study information | 2015/04/20 |
| Last modified on | 2021/10/08 14:46:19 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/04/20 12:37:26 | ||
| 2 | Update | 2015/04/20 19:16:26 | Co-sponsor Co-sponsor Organization1 Email1 |
|
| 3 | Update | 2015/04/21 21:41:38 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2015/08/13 17:10:56 | Recruitment status |
|
| 5 | Update | 2015/11/03 20:43:33 | Co-sponsor |
|
| 6 | Update | 2015/11/03 20:49:27 | Co-sponsor Co-sponsor |
|
| 7 | Update | 2015/11/03 20:50:46 | Co-sponsor |
|
| 8 | Update | 2015/11/03 21:03:44 | Co-sponsor |
|
| 9 | Update | 2016/10/24 19:19:25 | Study type |
|
| 10 | Update | 2016/10/24 19:20:25 | Name of primary person or sponsor Organization |
|
| 11 | Update | 2020/04/03 10:46:59 | Recruitment status Date of IRB Last follow-up date |
|
| 12 | Update | 2021/10/08 14:38:01 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results |
|
| 13 | Update | 2021/10/08 14:44:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
|
| 14 | Update | 2021/10/08 14:45:58 | Recruitment status Date analysis concluded |
|
| 15 | Update | 2021/10/08 14:46:19 | Publication of results |
